News | Blood Testing | September 04, 2018

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

Prevencio’s multi-protein, AI-driven HART PAD biomarker test has potential to improve clinical outcomes and reduce costs in the treatment of diabetic patients

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient

September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD) in diabetes mellitus (DM) patients, a patient population in which PAD prevalence has traditionally been difficult to assess. Researchers believe these findings, presented at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-28 in Munich, Germany, could lead to early identification of PAD and improve patient clinical outcomes, as well as prevent patients without PAD from undergoing unnecessary, expensive and invasive tests.

The study is follow-on to data presented at the American Diabetes Association (ADA) 2018 Scientific Sessions in June demonstrating Prevencio’s HART CAD and HART CVE tests accurately diagnose coronary artery disease (CAD) and predict the risk for major adverse cardiac events (MACE) in DM patients. Similar to CAD, PAD is commonly due to atherosclerosis, a plaque buildup in the arteries which restricts blood flow.

In this study, researchers assessed the company’s artificial intelligence (AI)-driven HART PAD diagnostic test on patients enrolled in Massachusetts General Hospital’s (MGH) Catheter Sampled Blood Archive in Cardiovascular Disease (CASABLANCA) study. The HART PAD test algorithmically assesses six biomarkers linked to atherosclerosis, as well as a patient’s history of hypertension. In patients with DM, the HART PAD panel had excellent performance for diagnosis of PAD. Using a five-point score, a score of 1 had a 100 percent negative predictive value (NPV) and a score of 5 had a 95 percent positive predictive value (PPV). Additionally, the HART PAD panel was highly accurate in predicting the need for revascularization in patients with PAD. These results were comparable to those patients without DM.

Principal investigator James L. Januzzi, M.D., practicing cardiologist at MGH and professor of medicine at Harvard Medical School, said, “The HART PAD test may allow for the diagnosis and treatment of many more patients with currently undetected PAD. In the clinical setting, these findings could assist physicians to identify peripheral artery disease earlier, provide guideline-recommended care and monitor at-risk patients for vascular complications. We believe HART tests could also play an important role in identifying high-risk patients for enrollment in clinical trials, thereby saving time and lowering overall trial costs.”

PAD affects more than 202 million people worldwide and is often underdiagnosed and undertreated until the disease has reached advanced stages. Patients with DM are at substantial risk of developing PAD. Patients with PAD have increased risk of CAD, heart attack or stroke and, if left untreated, PAD can lead to foot or leg amputation.

For more information: www.prevenciomed.com


Related Content

News | Artificial Intelligence

May 19, 2023 — Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine ...

Home May 19, 2023
Home
News | Artificial Intelligence

May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the ...

Home May 09, 2023
Home
News | Artificial Intelligence

May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or ...

Home May 04, 2023
Home
News | Artificial Intelligence

May 2, 2023 — Ambiq, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in ...

Home May 02, 2023
Home
News | Artificial Intelligence

April 26, 2023 —Ascend Cardiovascular, a leader in cardiovascular structured reporting and workflow solutions is ...

Home April 26, 2023
Home
Videos | Artificial Intelligence

Successfully creating and implementing artificial intelligence (AI) and analytic solutions in general requires a number ...

Home April 26, 2023
Home
Videos | Artificial Intelligence

With the help of artificial intelligence, cutting-edge technology is being developed that will help improve patient ...

Home April 25, 2023
Home
News | Artificial Intelligence

April 18, 2023 — HeartFlow, Inc. announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT ...

Home April 18, 2023
Home
News | Artificial Intelligence

April 17, 2023 — GE HealthCare, a leader in health technology, will showcase its growing portfolio of digital platforms ...

Home April 17, 2023
Home
News | Artificial Intelligence

April 17, 2023 — eClinicalWorks, an ambulatory cloud EHR, today announced it is advancing its intelligent cloud ...

Home April 17, 2023
Home
Subscribe Now